We are honored to announce a call for nominations for the 12th annual Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research. The Pancreas Center at Columbia University and The Herbert Irving Comprehensive Cancer Center have been entrusted by the Siegel family to identify the investigator who has made the most impactful contribution to the understanding and/or treatment of pancreatic cancer over the past year.
Study of AI’s ability to diagnose pancreatic cancer: John A. Chabot, MD, Executive Director of The Pancreas Center speaks about this study and where we go now.
A groundbreaking Phase II clinical trial for a mRNA neoantigen vaccine for pancreatic cancer is underway. With a mortality rate of nearly 90 percent, this could be a transformative development in the treatment of pancreatic cancer. Dr. John Chabot shares what you need to know.
We are thrilled to announce the winners of the 2023 Ruth Leff Seigel Awards for pancreatic cancer research, Pat Gulhati, MD, PhD and Fay Kastrinos, MD.
We are honored to announce a call for nominations for the 11th annual Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research. The Pancreas Center at Columbia University and The Herbert Irving Comprehensive Cancer Center have been entrusted by the Siegel family to identify the investigator who has made the most impactful contribution to the understanding and/or treatment of pancreatic cancer over the past year.
